| 02/03/26 | 16:56:52 | 2 Mar 2026 | | Total Voting Rights |
| 02/03/26 | 07:00:09 | 2 Mar 2026 | | Transaction in Own Shares |
| 27/02/26 | 07:00:08 | 27 Feb 2026 | | Transaction in Own Shares |
| 26/02/26 | 07:05:00 | 26 Feb 2026 | | Launch of Buyback Programme |
| 26/02/26 | 07:00:09 | 26 Feb 2026 | | Final Results, Share Buyback & Leadership Changes |
| 04/02/26 | 17:29:01 | 4 Feb 2026 | | Statement regarding Hikma Pharmaceuticals Plc |
| 03/02/26 | 07:00:10 | 3 Feb 2026 | | Notice of Results |
| 19/12/25 | 15:50:50 | 19 Dec 2025 | | Director/PDMR Shareholding |
| 19/12/25 | 15:43:55 | 19 Dec 2025 | | Director/PDMR Shareholding |
| 15/12/25 | 15:59:02 | 15 Dec 2025 | | Director/PDMR Shareholding |
| 15/12/25 | 07:00:08 | 15 Dec 2025 | | Hikma announces CEO change and Board appointment |
| 11/11/25 | 12:13:10 | 11 Nov 2025 | | Holding(s) in Company |
| 11/11/25 | 11:42:39 | 11 Nov 2025 | | Director/PDMR Shareholding |
| 07/11/25 | 12:56:15 | 7 Nov 2025 | | Director/PDMR Shareholding |
| 06/11/25 | 07:00:08 | 6 Nov 2025 | | November Trading Statement |
| 01/10/25 | 11:45:49 | 1 Oct 2025 | | Block listing Interim Review |
| 23/09/25 | 13:52:26 | 23 Sept 2025 | | Director/PDMR Shareholding |
| 17/09/25 | 09:16:19 | 17 Sept 2025 | | Director/PDMR Shareholding |
| 22/08/25 | 12:02:27 | 22 Aug 2025 | | Director/PDMR Shareholding |
| 13/08/25 | 13:51:22 | 13 Aug 2025 | | Director/PDMR Shareholding |
| 08/08/25 | 12:59:04 | 8 Aug 2025 | | Director/PDMR Shareholding |
| 07/08/25 | 07:00:09 | 7 Aug 2025 | | Half-year Report |
| 09/07/25 | 09:00:00 | 9 Jul 2025 | | Notice of Results |
| 07/07/25 | 09:16:54 | 7 Jul 2025 | | Publication of Offering Circular |
| 09/06/25 | 15:33:10 | 9 Jun 2025 | | Director/PDMR Shareholding |
| 05/06/25 | 14:05:13 | 5 Jun 2025 | | Director/PDMR Shareholding |
| 03/06/25 | 13:02:56 | 3 Jun 2025 | | Director/PDMR Shareholding |
| 29/05/25 | 07:00:09 | 29 May 2025 | | Fitch upgrades Hikma to ‘BBB’ |
| 20/05/25 | 14:49:02 | 20 May 2025 | | Director/PDMR Shareholding |
| 15/05/25 | 12:00:00 | 15 May 2025 | | Medium-term Group guidance ahead of US site visit |
| 08/05/25 | 16:35:30 | 8 May 2025 | | Director/PDMR Shareholding |
| 08/05/25 | 10:48:18 | 8 May 2025 | | S&P upgrades Hikma to ‘BBB’ |
| 08/05/25 | 08:21:24 | 8 May 2025 | | Settlement agreement for Xyrem® US lawsuits |
| 30/04/25 | 13:21:13 | 30 Apr 2025 | | Director/PDMR Shareholding |
| 24/04/25 | 15:55:39 | 24 Apr 2025 | | Result of AGM |
| 24/04/25 | 07:00:08 | 24 Apr 2025 | | Trading Statement |
| 10/04/25 | 14:36:41 | 10 Apr 2025 | | Director/PDMR Shareholding |
| 08/04/25 | 13:47:17 | 8 Apr 2025 | | Director/PDMR Shareholding |
| 01/04/25 | 09:30:52 | 1 Apr 2025 | | Block listing Interim Review |
| 19/03/25 | 10:10:59 | 19 Mar 2025 | | Annual Financial Report and Notice of AGM |
| 04/03/25 | 11:16:20 | 4 Mar 2025 | | Director/PDMR Shareholding |
| 26/02/25 | 07:00:07 | 26 Feb 2025 | | Final Results |
| 10/02/25 | 08:09:41 | 10 Feb 2025 | | Notice of Results |
| 23/12/24 | 09:46:39 | 23 Dec 2024 | | Director/PDMR Shareholding |
| 07/11/24 | 15:30:51 | 7 Nov 2024 | | Outcome of Audit Tender Process |
| 07/11/24 | 07:00:03 | 7 Nov 2024 | | Trading Statement |
| 24/10/24 | 07:00:01 | 24 Oct 2024 | | 2024 Annual General Meeting Update Statement |
| 01/10/24 | 09:45:02 | 1 Oct 2024 | | Block listing Interim Review |
| 24/09/24 | 10:09:36 | 24 Sept 2024 | | Director/PDMR Shareholding |
| 10/09/24 | 07:00:07 | 10 Sept 2024 | | Hikma completes Xellia acquisition |
